| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/17/2014 | WO2014058394A1 Method of prognosis and stratification of ovarian cancer |
| 04/17/2014 | WO2014057432A2 Multicomponent lipid nanoparticles and processes for the preparation thereof |
| 04/17/2014 | WO2014056414A1 Reduction stimuli-responsive gene vector system and preparation and use thereof |
| 04/17/2014 | WO2014022475A3 Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers |
| 04/17/2014 | WO2012112578A3 Improved aav8 vector with enhanced functional activity and methods of use thereof |
| 04/17/2014 | US20140107227 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 04/17/2014 | US20140107191 Method for enhanced uptake of viral vectors in the myocardium |
| 04/17/2014 | US20140107041 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 04/17/2014 | US20140106450 Compositions and Methods for Inhibiting Expression of a Target Gene |
| 04/17/2014 | US20140105861 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders |
| 04/16/2014 | EP2719380A2 SUR1 inhibitors for therapy |
| 04/16/2014 | EP2717924A1 Modulation of pancreatic beta cell proliferation |
| 04/16/2014 | EP2717923A2 Methods for modulating kallikrein (klkb1) expression |
| 04/16/2014 | EP2717922A2 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 04/16/2014 | EP2717921A2 Retinoid-liposomes for enhancing modulation of hsp47 expression |
| 04/16/2014 | EP2717911A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer |
| 04/16/2014 | CN103732258A Oral formulations for promoting cellular purification |
| 04/16/2014 | CN103732249A Influenza vaccines containing modified adenovirus vectors |
| 04/16/2014 | CN103725713A Application of pegylation chitosan serving as nucleic acid vector |
| 04/16/2014 | CN103725682A Small interfering ribonucleic acid (RNA) for knocking down expression of estrogen related receptor (ERR), and recombinant vector and application of RNA |
| 04/16/2014 | CN103721269A Lipidosome-protected nano-gold gene vector and preparation method thereof |
| 04/16/2014 | CN103721268A Application of miR-150 inhibitor in preparation of colorectal cancer drug resistance reversal agent |
| 04/16/2014 | CN102888426B Minicircle gene vector and its preparation method and use |
| 04/16/2014 | CN102660551B VHH (variable domain of heavy chain of heavy-chain antibody) antibody gene derived from anti-CyPA (CyclophilinA) animal of family Camelidae, encoded polypeptide, and application thereof |
| 04/16/2014 | CN102657878B Application of small activating RNA (Ribonucleic Acid) of INTS6 (Homo Sapiens Integrator Complex Subunit 6) gene to preparation of prostate cancer fighting medicament |
| 04/16/2014 | CN102634531B Medicine T-VISA-PEA15 capable of effectively and specifically killing breast cancer cells |
| 04/16/2014 | CN102517332B EGF (epidermal growth factor)-modified PAMAM (polyamidoamine) self-assembled composite for transgenosis as well as preparation method and applications thereof |
| 04/16/2014 | CN102516382B Antimicrobial peptide Hainanenin-5 of Amolops hainanensis, gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis, and application of gene of antimicrobial peptide Hainanenin-5 of Amolops hainanensis |
| 04/16/2014 | CN102399870B Reagent for determining survival and prognosis of patients with esophagus cancer |
| 04/16/2014 | CN102083983B Small RNS interference target site sequences of hepatitis B virus and small interference RNAs and the compositions and uses thereof |
| 04/15/2014 | US8697859 MicroRNA and methods for inhibiting same |
| 04/15/2014 | US8697667 Cyclodextrin-modified polyamines for delivery of therapeutic molecules |
| 04/15/2014 | US8697665 Porphobilinogen deaminase gene therapy |
| 04/15/2014 | US8697663 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
| 04/15/2014 | US8697395 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 04/15/2014 | US8697077 Methods and compositions for treating autoimmune diseases |
| 04/15/2014 | US8697065 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/15/2014 | US8697050 Methods of treatment using a vector encoding p21/Cip1 |
| 04/15/2014 | CA2600749C Dimeric or multimeric microproteins |
| 04/15/2014 | CA2547899C Cell-based therapies for ischemia |
| 04/15/2014 | CA2399298C Use of il-18 inhibitors |
| 04/15/2014 | CA2383877C Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 04/10/2014 | WO2014055771A1 Human alpha-folate receptor chimeric antigen receptor |
| 04/10/2014 | WO2014055682A1 Immunomodulatory minicells and methods of use |
| 04/10/2014 | WO2014055657A1 Use of a trans-signaling approach in chimeric antigen receptors |
| 04/10/2014 | WO2014055515A1 Use of p3 of bacteriophage fusion proteins as amyloid binding agents |
| 04/10/2014 | WO2014055413A2 A method of providing cellular therapy using modified natural killer cells or t lymphocytes |
| 04/10/2014 | WO2014054588A1 Nanogel/exosome complex and dds |
| 04/10/2014 | WO2014053871A1 A method for screening a compound capable of inhibiting the notch1 transcriptional activity |
| 04/10/2014 | WO2014053014A1 Modulation of rna activity and vascular permeability |
| 04/10/2014 | WO2013173512A3 High-transduction-efficiency raav vectors, compositions, and methods of use |
| 04/10/2014 | WO2012075114A3 Nucleic acid-polymer conjugates and uses thereof |
| 04/10/2014 | US20140100261 Trpm-2 antisense therapy |
| 04/10/2014 | US20140099307 New Dendritic Cell Co-Stimulatory Molecules |
| 04/10/2014 | US20140099286 Cell therapy for chronic stroke |
| 04/10/2014 | US20140099284 Modulation neural pathways |
| 04/09/2014 | EP2716764A1 Construction and application of mutant type b human adenovirus ad11 having enhanced oncolytic power |
| 04/09/2014 | EP2716758A1 OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSIS, AND OLIGONUCLEOTIDE DERIVATIVE FOR REGULATION OF miRNA FUNCTION |
| 04/09/2014 | EP2716756A1 Reic-expressing adenovirus vector |
| 04/09/2014 | EP2716304A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME |
| 04/09/2014 | EP2714903A1 Suv39h2 as a target gene for cancer therapy and diagnosis |
| 04/09/2014 | EP2714096A1 Compositions and methods for transport across the blood brain barrier |
| 04/09/2014 | EP2714065A2 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| 04/09/2014 | CN103717738A Drug composition for cancer treatment and/or prevention |
| 04/09/2014 | CN103717735A Technique for cleaving out part of poly(a) chain and/or 3'-terminal sequence of mRNA to inhibit translation reaction |
| 04/09/2014 | CN103717240A Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 04/09/2014 | CN103710384A Picornaviridae recombinant vector, virus like particle, and preparation method and use of virus like particle |
| 04/09/2014 | CN103710383A Non-virus transgenic vector, preparation method and applications thereof |
| 04/09/2014 | CN103710345A Small non-coding RNA (ribonucleic acid) molecule BSR0601 from Brucella melitensis and application thereof |
| 04/09/2014 | CN103709250A Human monoclonal antibodies against CD20 |
| 04/09/2014 | CN103705945A Application of CUG-BP1 (cytosine-uridineguanine-binding protein 1) and gene thereof in preparation of products for controlling and treating muscle atrophy diseases |
| 04/09/2014 | CN103705924A Combined application of miR-1255a and tumor treating medicine |
| 04/09/2014 | CN103705923A Method and reagent used for inhibiting tumor metastasis |
| 04/09/2014 | CN103705920A Cytoplasmic polyadenylation element-binding protein 4 vaccine, and preparation and application thereof |
| 04/09/2014 | CN103705465A Slightly acidic environment targeted polypeptide modified tumor targeted nano drug delivery system, and preparation method thereof |
| 04/09/2014 | CN103705464A Tumor active targeting nano drug delivery system controlled by slightly acidic environment, and preparation method thereof |
| 04/09/2014 | CN102816742B Chimeric adenoviruses for use in cancer treatment |
| 04/09/2014 | CN102666480B Aromatic compound, modification carrier that uses same and is used for synthesizing oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct |
| 04/09/2014 | CN102154290B SiRNAs for inhibiting epidemic encephalitis B viruses |
| 04/09/2014 | CN101652381B Enzymes for treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 04/08/2014 | US8691967 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
| 04/08/2014 | US8691948 Methods and compositions for treating brain diseases |
| 04/08/2014 | US8691786 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA |
| 04/08/2014 | US8691785 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 04/08/2014 | US8691783 MicroRNA-24 |
| 04/08/2014 | US8691533 Inducible gene expression |
| 04/08/2014 | US8691503 Method and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 04/08/2014 | US8691230 Methods for inhibiting hematopoiesis with a hedgehog antagonist |
| 04/08/2014 | US8691212 Therapeutic/prophylactic agent for prostate cancer |
| 04/08/2014 | US8691211 Suppression of immune response to factor VIII in hemophilia A patients |
| 04/08/2014 | US8691208 Compositions and methods for treating hypophosphatasia |
| 04/08/2014 | CA2527958C Methods and compositions for enhancing the efficacy and specificity of rnai |
| 04/08/2014 | CA2524229C Canine ghrh gene, polypeptides and methods of use |
| 04/03/2014 | WO2014052789A1 Aav vectors targeted to oligodendrocytes |
| 04/03/2014 | WO2014052693A2 Veterinary composition and methods for non-surgical neutering and castration |
| 04/03/2014 | WO2014052555A1 Compositions and methods for treating hepatitis b |
| 04/03/2014 | WO2014051519A1 Telomerase inhibitors for use in therapy |
| 04/03/2014 | WO2014048565A1 Mitochondrial expression vector and method for the transformation of mitochondria |
| 04/03/2014 | WO2014018689A3 Novel monomeric yellow-green fluorescent protein from cephalochordate |
| 04/03/2014 | WO2014018423A3 Inducible dna binding proteins and genome perturbation tools and applications thereof |